Back

MedAll, Partners for Advancing Clinical Education

  • Antibodies, Bispecific
  • Lung Neoplasms

Evolving Paradigms in Lung Cancer: Module 4 Decision Trees for Patient Selection and Monitoring

Join Dr. Joshua Sabari as he explores the practical management of adverse events associated with emerging PD-(L)1 × VEGF bispecific antibodies in lung cancer. This expert-led microlearning module reviews the recognition and management of VEGF- and immune-mediated toxicities, highlights strategies for proactive monitoring, and discusses how multidisciplinary collaboration can optimize treatment delivery and patient outcomes in clinical practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.25 creditsAAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • includes Online course / module
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Jul 22, 2026
  • Last day to claim credit
    Jul 15, 2027 9 months left